en

PRODUCT DETAIL

Flixotide 125 Inhaler N

Code 13972
MA number 14/0141/15-S
Product Form: sus inh 1x60 dávok (nád.tlak.Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: National
Therapeutic Class: 14 - BRONCHODILATANTIA, ANTIASTHMATICA
ATC:
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
R03BA Glucocorticoids
R03BA05 Fluticasone
Shelf life: 24
Container: pressurised container, aluminium
Route of admin.: Inhalation use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 20.06.1995
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_Flixotide Inhaler N_10.2021.pdf  
SPC: SPC_Flixotide Inhaler N_10.2021.pdf  
Safety feature Yes
Data update: 14.12.2018
eu-flag.png sk-flag.png